The anaemia control model: Does it help nephrologists in therapeutic decision-making in the management of anaemia?

Introduction: Anaemia is common in haemodialysis patients and treating it with erythropoiesis-stimulating agents (ESAs) is complex due to many factors.

Objectives: To assess the usefulness of the Anaemia Control Model (ACM) in the treatment of anaemia in haemodialysis.

Methods: ACM is a software that predicts the optimal dose of darbepoetin and iron sucrose to achieve target haemoglobin (Hb) and ferritin levels, and makes prescription suggestions.